Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era

AIDS Research and Human Retroviruses

Volumn 23, Issue 8, 2007, Pages 965-971

  Sirera, Guillem ^a,b   Videla, Sebastià ^a,b   López Blázquez, Raquel ^c   Llatjos, Mariona ^a   Tarrats, Antoni ^a,b   Castellà, Eva ^a   Grane, Nuria ^a,b   Alcalde, Carmen ^a   Tural, Cristina ^a,b   Rey Joly, Celestino ^a   Clotet, Bonaventura ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; EVOLUTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; SURVIVAL; UTERINE CERVIX CYTOLOGY; UTERUS CARCINOMA; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; RETROSPECTIVE STUDIES; VAGINAL SMEARS; VIRAL LOAD;

EID: 34848909810     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0293     Document Type: Article

References (35)

1. Walboomers JMM, Jacobs MV, Manos MM, et al.: Human papillomavirus types associated with cervical cancer. J Pathol 1999;189: 12-19.
2. Muñoz N, Bosch FX, De Sanjosé S, et al.: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;384:518-527.
3. Wright TC Jr, Ellerbrock TV, Chiasson MA, et al.: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994;84:591-597.
4. Conti M, Agarossi A, Parazzini F, Muggiasca ML, et al.: HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol 1993;49:344-348.
5. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, et al.: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-1349.
6. Minkoff H, Ahdieh L, Massad LS, et al.: The effect of highly active antiretroviral therapy on cervical changes associated with oncogenetic HPV among HIV infected women. AIDS 2001;15: 2157-2164.
7. Palefsky JM: Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003;15:382-388.
8. Uberti-Foppa C, Ferrari D, Lodini S, et al.: Long term of highly active antiretroviral therapy on cervical lesions in HIV positive women. AIDS 2003;17:2136-2138.
9. Heard I, Schmitz V, Costagliola D, et al.: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459-1464.
10. Schuman P, Ohmit SE, Klein RS, et al.: HIV Epidemiology Research Study (HERS) Group. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003;188:128-136.
11. Lillo FB, Ferrari D, Veglia F, et al.: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-551.
12. Del Mistro A, Bertorelle R, Franzetti M, et al.: Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis 2004;38: 737-742.
13. Heard I, Tassie JM, Kazatchkine MD, and Orth G: Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002;16:1799-1802.
14. Heard I, Potard V, and Costagliola D: Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Antiviral Ther 2006;11:1091-1096.
15. Ahdieh-Grant L, Li R, Levine AM, et al.: Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004;96:1070-1076.
16. National Cancer Institute Workshop: The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-934.
17. Kinney WK, Manos MM, Hurley LB, and Ransley JE: Where's the high-grade cervical neoplasia? The importance of the minimally abnormal Papanicolaou test. Obstet Gynecol 1998;91:973-976.
18. Holcomb K, Abulafia O, Matthews RP, et al.: The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol 1999;75:118-121.
19. Duerr A, Paramsothy P, Jamieson DJ. et al.: HIV Epidemiology Research Study. Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42: 855-861.
20. Vernon SD, Hart CE, Reeves WC, and Icenogle JP: The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993;27:133-145.
21. Massad LS, Ahdieh L, Benning L, et al.: Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr 2001;27:432-442.
22. Dolei A, Curreli S, Marongiu P, et al.: Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J Gen Virol 1999;80:2937-2944.
23. Wilkinson EJ: Pap smears and screening for cervical neoplasia. Clin Obstet Gynecol 1990;33:817-825.
24. Harris TG, Buck RD, Palefsky JM, et al.: Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005;293:1471-1476.
25. Ellerbrock TV, Chiasson MA, Bush TJ, et al.: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-1037.
26. Minkoff H, Feldman J, DeHovitz J, et al.: A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998;178:982-986.
27. Maiman M, Fruchter RG, Sedlis A, et al.: Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-239.
28. Ho GY, Burk RD, Klein S, et al.: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-1371.
29. Ahdieh L, Klein RS, Burk R, et al.: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001;184:682-690.
30. Schiffman MH and Brinton LA: The epidemiology of cervical carcinogenesis. Cancer 1995;76:1888-1901.
31. Kobayashi A, Greenblatt RM, Anastos K, et al.: Functional Attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 2004;64: 6766-6774.
32. Haga T, Kim SH, Jensen RH, et al.: Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV positive and HIV negative men. J Acquir Immune Dis Syndr 2001;26:256-262.
33. Solomon D, Schiffman M, and Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
34. Stoler MH and Schiffman M: Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.
35. Selvaggi SM: Implications of low diagnostic reproducibility of cervical cytologic and histologic diagnoses. JAMA 2001;285:1506-1508.